Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00414661 · ClinicalTrials.gov registry record

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

A clinical trial of Arthritis, Rheumatoid, sponsored by Pfizer.

Completed
Registry status
162
Enrollment target
20
Study locations

NCT00414661 is a study of Arthritis, Rheumatoid that has completed, run by Pfizer. The registered enrollment target is 162 participants, below the 635-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00414661, a study of Arthritis, Rheumatoid, has completed, sponsored by Pfizer.

COMPLETED
Registry status
162 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Conditions Studied

Arthritis, Rheumatoid

Interventions

  • DRUG CP-690,550

Study Locations (20)

Florida

  • Pfizer Investigational Site - Ocala
  • Pfizer Investigational Site - Orlando
  • Pfizer Investigational Site - Sarasota
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - Tampa
  • Pfizer Investigational Site - Venice

California

  • Pfizer Investigational Site - Palo Alto
  • Pfizer Investigational Site - San Diego
  • Pfizer Investigational Site - Stanford
  • Pfizer Investigational Site - Upland

Arizona

  • Pfizer Investigational Site - Gilbert
  • Pfizer Investigational Site - Tucson

North Carolina

  • Pfizer Investigational Site - Hickory
  • Pfizer Investigational Site - Hickory

Illinois

  • Pfizer Investigational Site - Rockford

Nebraska

  • Pfizer Investigational Site - Lincoln

New York

  • Pfizer Investigational Site - Albany

Pennsylvania

  • Pfizer Investigational Site - Wyomissing

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2007-04
Est. Completion 2012-02

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00414661

The ClinicalTrials.gov registry entry for NCT00414661 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 635-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (74% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which CP-690,550 is the first listed.

NCT00414661 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT00414661 about?

NCT00414661 is a clinical study titled "Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550". The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

What is the current status of trial NCT00414661?

This trial is currently completed. The enrollment target is 162 participants. The study started on 2007-04. Estimated completion is 2012-02.

What conditions does trial NCT00414661 study?

This clinical trial studies the following conditions: Arthritis, Rheumatoid.

What interventions are being tested in trial NCT00414661?

The interventions under investigation include: CP-690,550 (DRUG).

Who is sponsoring clinical trial NCT00414661?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00414661 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Arthritis, Rheumatoid

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Arthritis, Rheumatoid

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.